Skip to content
Clinical Trials – home

DermoDent Centrum Medyczne Aldona Czajkowska Rafal Czajkowski s.c.

Verified siteinfo

Poland ul. Tuberozy 3, 86-031 Osielsko, Poland

  • 2 trials recruiting
  • Vitiligo · Psoriasis
  • Adults and children

About Specializations

DermoDent Centrum Medyczne Aldona Czajkowska Rafal Czajkowski s.c. in Osielsko, Poland specialises in clinical trials of conditions such as Vitiligo, Psoriasis, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology

The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions. The ongoing studies aim to enhance the understanding and management of complex dermatological disorders.

  • Moderate-to-Severe Plaque Psoriasis

Through extensive research, the center is dedicated to improving the long-term safety and efficacy of novel therapeutic agents, providing hope for patients with challenging skin conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Tuberozy 386-031 OsielskoPoland
Recruiting now
2 trials
Conditions studied
2
Partner status
Verified site

More sites in OsielskoPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Vitiligo

Recruiting

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Vitiligo

Recruiting

Safety and efficacy of oral ACT-777991 in adults with non‑segmental vitiligo: a randomized, double‑blind, placebo‑controlled Phase 2a trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Idorsia Pharmaceuticals Ltd.

Psoriasis

Not recruiting

Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Takeda Development Center Americas Inc.

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Vitiligo

Not recruiting

Study on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Psoriasis

Not recruiting

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Vitiligo

Not recruiting

Study on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.